Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Sunshine Heart Announces Receipt of Nasdaq Staff Determination; To Request Hearing
Posted on Sep 23, 2016
EDEN PRAIRIE, Minn., Sept. 23, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that on September 21, 2016, it received a letter from the Nasdaq Listing Qualifications Staff indicating that the Company did not timely demonstrate compliance with the $1.00 bid price require...

Read More

Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted on Aug 25, 2016
EDEN PRAIRIE, Minn., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on August 18, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved four equity awards, to be effective as of August 22...

Read More

Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016
Posted on Aug 18, 2016
EDEN PRAIRIE, Minn., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and Chairman of the Board, John Erb, is scheduled to present at the 2016 investMNt Conference in Minneapolis, MN on August 24th at 11:45 AM CT. To access t...

Read More

View all press releases »

Events & Presentations

2016 investMNt Conference
Posted on Aug 24, 2016 at 11:45 AM CT
Sunshine Heart Second Quarter 2016 Earnings
Posted on Aug 9, 2016 at 9:00 AM ET
Sunshine Heart 2016 Annual Meeting of Stockholders
Posted on May 26, 2016 at 3:30 AM CT
View all events & presentations »